SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-175829
Filing Date
2015-05-07
Accepted
2015-05-07 07:02:18
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d905491d10q.htm 10-Q 484458
2 EX-10.1 d905491dex101.htm EX-10.1 49632
3 EX-31.1 d905491dex311.htm EX-31.1 6430
4 EX-31.2 d905491dex312.htm EX-31.2 6421
5 EX-32.1 d905491dex321.htm EX-32.1 4007
6 EX-32.2 d905491dex322.htm EX-32.2 3986
  Complete submission text file 0001193125-15-175829.txt   3031892

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT srpt-20150331.xml EX-101.INS 368579
8 XBRL TAXONOMY EXTENSION SCHEMA srpt-20150331.xsd EX-101.SCH 26430
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srpt-20150331_cal.xml EX-101.CAL 50580
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srpt-20150331_def.xml EX-101.DEF 51819
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20150331_lab.xml EX-101.LAB 203974
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20150331_pre.xml EX-101.PRE 146200
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 15839349
SIC: 2834 Pharmaceutical Preparations